Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
about
Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer modelUse of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer.Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci.Transfection of oocytes and other types of ovarian cells in rabbits after direct injection into uterine arteries of adenoviruses and plasmid/liposomes.Gastrointestinal hyperplasia with altered expression of DNA polymerase beta.Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from B6C3F1 mice exposed to cumene.Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium.Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities.Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathwayOverview of the molecular carcinogenesis of mouse lung tumor models of human lung cancerATM mediates pRB function to control DNMT1 protein stability and DNA methylation.Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomasLoss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.Hematopoietic stem cell ageing is uncoupled from p16 INK4A-mediated senescence.New tools in therapeutic research--prostatic cancer and models.Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
P2860
Q30494652-B1E18E92-B58C-4872-B279-5A87304D1E3DQ30724678-EA9465D6-1176-4FB5-80A3-2FBB7AAC6F84Q30744989-76E1AD8F-74C8-4C00-8F8A-8203E0E0B31AQ30901473-BFBB397A-46B6-4A0F-BEA6-E1B9C17C2032Q33490616-6C1794A7-B26F-4823-8FDB-1D3B91FCBF6CQ33579847-6FF1C65E-A7EE-4E80-AA2A-B2D796DCE348Q33835721-6EFFEE9C-D9FC-4A1D-80B6-9D7759BBCB9DQ34440754-01AA7FE3-BBB3-4044-8760-13271ABFBAA2Q34571504-A070A72D-615C-40E9-9DF8-6457EA719DC2Q35882119-4773FE74-784E-4F07-8985-C3DCB4F50AB9Q36088646-83FCD80B-3617-489F-B7F5-EDCC5ADAD78AQ36169372-9F20715F-7340-458E-9599-1EA33B8304C5Q37122929-191D39C7-3336-4A90-8245-76E27E373D43Q40424591-FF4BAA4A-0B4B-4335-A372-825E975AAFFAQ43729274-1C615E5C-EE9D-4A94-87FA-F38151394472Q47928877-6631724B-17CE-41A2-B7C2-12AC4E8FA4DFQ53671417-AAB1A6DC-2C73-468D-A23F-84E162B5C9E7Q55474891-6D11BAD8-FDE2-4BBD-BDB1-2A0DE47C745F
P2860
Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Hypermethylation of the p16 (I ...... mas and mouse lung cell lines.
@ast
Hypermethylation of the p16 (I ...... mas and mouse lung cell lines.
@en
type
label
Hypermethylation of the p16 (I ...... mas and mouse lung cell lines.
@ast
Hypermethylation of the p16 (I ...... mas and mouse lung cell lines.
@en
prefLabel
Hypermethylation of the p16 (I ...... mas and mouse lung cell lines.
@ast
Hypermethylation of the p16 (I ...... mas and mouse lung cell lines.
@en
P2093
P2860
P356
P1433
P1476
Hypermethylation of the p16 (I ...... mas and mouse lung cell lines.
@en
P2093
J C Barrett
P S Stockton
T R Devereux
P2860
P304
P356
10.1093/CARCIN/21.9.1691
P407
P577
2000-09-01T00:00:00Z